# Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

> **NCT05614544** · PHASE1 · COMPLETED · sponsor: **Haisco-USA Pharmaceuticals, Inc.** · enrollment: 42 (actual)

## Conditions studied

- General Anesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05614544
- **Lead sponsor:** Haisco-USA Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-16
- **Primary completion:** 2023-10-03
- **Final completion:** 2023-10-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05614544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05614544, "Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT05614544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*